United States Botanical Drug Market Report & Forecast 2021-2027

1 Introduction to Research & Analysis Reports
1.1 Botanical Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Botanical Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Botanical Drug Overall Market Size
2.1 United States Botanical Drug Market Size: 2021 VS 2027
2.2 United States Botanical Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints

3 Company Landscape
3.1 Top Botanical Drug Players in United States Market
3.2 Top United States Botanical Drug Companies Ranked by Revenue
3.3 United States Botanical Drug Revenue by Companies
3.4 Top 3 and Top 5 Botanical Drug Companies in United States Market, by Revenue in 2020
3.5 Companies Botanical Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Botanical Drug Players in United States Market
3.6.1 List of Tier 1 Botanical Drug Companies in United States
3.6.2 List of Tier 2 and Tier 3 Botanical Drug Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Botanical Drug Market Size Markets, 2021 & 2027
4.1.2 Prescription Drug
4.1.3 OTC
4.2 By Type - United States Botanical Drug Revenue & Forecasts
4.2.1 By Type - United States Botanical Drug Revenue, 2016-2021
4.2.2 By Type - United States Botanical Drug Revenue, 2022-2027
4.2.3 By Type - United States Botanical Drug Revenue Market Share, 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Botanical Drug Market Size, 2021 & 2027
5.1.2 Cardiovascular
5.1.3 Tumor
5.1.4 Respiratory System
5.1.5 Others
5.2 By Application - United States Botanical Drug Revenue & Forecasts
5.2.1 By Application - United States Botanical Drug Revenue, 2016-2021
5.2.2 By Application - United States Botanical Drug Revenue, 2022-2027
5.2.3 By Application - United States Botanical Drug Revenue Market Share, 2016-2027

6 Botanical Drug Companies Profiles
6.1 Buchang Pharmaceuticals
6.1.1 Buchang Pharmaceuticals Company Details
6.1.2 Buchang Pharmaceuticals Business Overview
6.1.3 Buchang Pharmaceuticals Botanical Drug Introduction
6.1.4 Buchang Pharmaceuticals Botanical Drug Revenue in United States Market (2016-2021)
6.1.5 Buchang Pharmaceuticals Recent Developments
6.2 China TCM
6.2.1 China TCM Company Details
6.2.2 China TCM Business Overview
6.2.3 China TCM Botanical Drug Introduction
6.2.4 China TCM Botanical Drug Revenue in United States Market (2016-2021)
6.2.5 China TCM Recent Developments
6.3 Tsumura
6.3.1 Tsumura Company Details
6.3.2 Tsumura Business Overview
6.3.3 Tsumura Botanical Drug Introduction
6.3.4 Tsumura Botanical Drug Revenue in United States Market (2016-2021)
6.3.5 Tsumura Recent Developments
6.4 Schwabe
6.4.1 Schwabe Company Details
6.4.2 Schwabe Business Overview
6.4.3 Schwabe Botanical Drug Introduction
6.4.4 Schwabe Botanical Drug Revenue in United States Market (2016-2021)
6.4.5 Schwabe Recent Developments
6.5 Tong Ren Tang
6.5.1 Tong Ren Tang Company Details
6.5.2 Tong Ren Tang Business Overview
6.5.3 Tong Ren Tang Botanical Drug Introduction
6.5.4 Tong Ren Tang Botanical Drug Revenue in United States Market (2016-2021)
6.5.5 Tong Ren Tang Recent Developments
6.6 Jumpcan Pharmaceutical
6.6.1 Jumpcan Pharmaceutical Company Details
6.6.2 Jumpcan Pharmaceutical Business Overview
6.6.3 Jumpcan Pharmaceutical Botanical Drug Introduction
6.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue in United States Market (2016-2021)
6.6.5 Jumpcan Pharmaceutical Recent Developments
6.7 Guangzhou Baiyunshan Pharmaceutical
6.7.1 Guangzhou Baiyunshan Pharmaceutical Company Details
6.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
6.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Introduction
6.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue in United States Market (2016-2021)
6.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
6.8 Yunnan Baiyao
6.8.1 Yunnan Baiyao Company Details
6.8.2 Yunnan Baiyao Business Overview
6.8.3 Yunnan Baiyao Botanical Drug Introduction
6.8.4 Yunnan Baiyao Botanical Drug Revenue in United States Market (2016-2021)
6.8.5 Yunnan Baiyao Recent Developments
6.9 Tasly Holding Group
6.9.1 Tasly Holding Group Company Details
6.9.2 Tasly Holding Group Business Overview
6.9.3 Tasly Holding Group Botanical Drug Introduction
6.9.4 Tasly Holding Group Botanical Drug Revenue in United States Market (2016-2021)
6.9.5 Tasly Holding Group Recent Developments
6.10 Bionorica Se
6.10.1 Bionorica Se Company Details
6.10.2 Bionorica Se Business Overview
6.10.3 Bionorica Se Botanical Drug Introduction
6.10.4 Bionorica Se Botanical Drug Revenue in United States Market (2016-2021)
6.10.5 Bionorica Se Recent Developments
6.11 Huarun 999
6.11.1 Huarun 999 Company Details
6.11.2 Huarun 999 Business Overview
6.11.3 Huarun 999 Botanical Drug Introduction
6.11.4 Huarun 999 Botanical Drug Revenue in United States Market (2016-2021)
6.11.5 Huarun 999 Recent Developments
6.12 Taiji
6.12.1 Taiji Company Details
6.12.2 Taiji Business Overview
6.12.3 Taiji Botanical Drug Introduction
6.12.4 Taiji Botanical Drug Revenue in United States Market (2016-2021)
6.12.5 Taiji Recent Developments
6.13 Weleda
6.13.1 Weleda Company Details
6.13.2 Weleda Business Overview
6.13.3 Weleda Botanical Drug Introduction
6.13.4 Weleda Botanical Drug Revenue in United States Market (2016-2021)
6.13.5 Weleda Recent Developments
6.14 Kwangdong
6.14.1 Kwangdong Company Details
6.14.2 Kwangdong Business Overview
6.14.3 Kwangdong Botanical Drug Introduction
6.14.4 Kwangdong Botanical Drug Revenue in United States Market (2016-2021)
6.14.5 Kwangdong Recent Developments
6.15 GW Pharmaceuticals
6.15.1 GW Pharmaceuticals Company Details
6.15.2 GW Pharmaceuticals Business Overview
6.15.3 GW Pharmaceuticals Botanical Drug Introduction
6.15.4 GW Pharmaceuticals Botanical Drug Revenue in United States Market (2016-2021)
6.15.5 GW Pharmaceuticals Recent Developments

7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer

List of Tables
Table 1. Botanical Drug Market Opportunities & Trends in United States Market
Table 2. Botanical Drug Market Drivers in United States Market
Table 3. Botanical Drug Market Restraints in United States Market
Table 4. Key Players of Botanical Drug in United States Market
Table 5. Top Botanical Drug Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Botanical Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Botanical Drug Revenue Share by Companies, 2016-2021
Table 8. Companies Botanical Drug Product Type
Table 9. List of Tier 1 Botanical Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Botanical Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – United States Botanical Drug Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Botanical Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Botanical Drug Revenue (US$, Mn), 2022-2027
Table 14. By Application – United States Botanical Drug Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Botanical Drug Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Botanical Drug Revenue (US$, Mn), 2022-2027
Table 17. Buchang Pharmaceuticals Company Details
Table 18. Buchang Pharmaceuticals Business Overview
Table 19. Buchang Pharmaceuticals Botanical Drug Product
Table 20. Buchang Pharmaceuticals Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Buchang Pharmaceuticals Recent Developments
Table 22. China TCM Company Details
Table 23. China TCM Business Overview
Table 24. China TCM Botanical Drug Product
Table 25. China TCM Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. China TCM Recent Developments
Table 27. Tsumura Company Details
Table 28. Tsumura Business Overview
Table 29. Tsumura Botanical Drug Product
Table 30. Tsumura Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Tsumura Recent Developments
Table 32. Schwabe Company Details
Table 33. Schwabe Business Overview
Table 34. Schwabe Botanical Drug Product
Table 35. Schwabe Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Schwabe Recent Developments
Table 37. Tong Ren Tang Company Details
Table 38. Tong Ren Tang Business Overview
Table 39. Tong Ren Tang Botanical Drug Product
Table 40. Tong Ren Tang Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Tong Ren Tang Recent Developments
Table 42. Jumpcan Pharmaceutical Company Details
Table 43. Jumpcan Pharmaceutical Business Overview
Table 44. Jumpcan Pharmaceutical Botanical Drug Product
Table 45. Jumpcan Pharmaceutical Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Jumpcan Pharmaceutical Recent Developments
Table 47. Guangzhou Baiyunshan Pharmaceutical Company Details
Table 48. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 49. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product
Table 50. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Guangzhou Baiyunshan Pharmaceutical Recent Developments
Table 52. Yunnan Baiyao Company Details
Table 53. Yunnan Baiyao Business Overview
Table 54. Yunnan Baiyao Botanical Drug Product
Table 55. Yunnan Baiyao Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Yunnan Baiyao Recent Developments
Table 57. Tasly Holding Group Company Details
Table 58. Tasly Holding Group Business Overview
Table 59. Tasly Holding Group Botanical Drug Product
Table 60. Tasly Holding Group Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Tasly Holding Group Recent Developments
Table 62. Bionorica Se Company Details
Table 63. Bionorica Se Business Overview
Table 64. Bionorica Se Botanical Drug Product
Table 65. Bionorica Se Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Bionorica Se Recent Developments
Table 67. Huarun 999 Company Details
Table 68. Huarun 999 Business Overview
Table 69. Huarun 999 Botanical Drug Product
Table 70. Huarun 999 Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Huarun 999 Recent Developments
Table 72. Taiji Company Details
Table 73. Taiji Business Overview
Table 74. Taiji Botanical Drug Product
Table 75. Taiji Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. Taiji Recent Developments
Table 77. Weleda Company Details
Table 78. Weleda Business Overview
Table 79. Weleda Botanical Drug Product
Table 80. Weleda Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. Weleda Recent Developments
Table 82. Kwangdong Company Details
Table 83. Kwangdong Business Overview
Table 84. Kwangdong Botanical Drug Product
Table 85. Kwangdong Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 86. Kwangdong Recent Developments
Table 87. GW Pharmaceuticals Business Overview
Table 88. GW Pharmaceuticals Company Details
Table 89. GW Pharmaceuticals Botanical Drug Product
Table 90. GW Pharmaceuticals Botanical Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 91. GW Pharmaceuticals Recent Developments
List of Figures
Figure 1. Botanical Drug Segment by Type
Figure 2. Botanical Drug Segment by Application
Figure 3. United States Botanical Drug Market Overview: 2020
Figure 4. United States Botanical Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Botanical Drug Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Botanical Drug Revenue in 2020
Figure 7. By Type - United States Botanical Drug Revenue Market Share, 2016-2027
Figure 8. By Application - United States Botanical Drug Revenue Market Share, 2016-2027
Figure 9. Buchang Pharmaceuticals Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. China TCM Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Tsumura Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Schwabe Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Tong Ren Tang Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Jumpcan Pharmaceutical Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Yunnan Baiyao Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Tasly Holding Group Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Bionorica Se Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Huarun 999 Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Taiji Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Weleda Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Kwangdong Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. GW Pharmaceuticals Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.